AI startup to hire 100 developers in PH
Artificial intelligence (AI)-powered startup engaged in pre-cancer screening plans InterVenn Biosciences is interested in hiring over 100 software developers and engineers in the Philippines.
According to the Board of Investments (BOI), InterVenn Biosciences General Manager Axel Kornerup and Chief Information Security Office Randolph Barr said that the software developers and engineers would form the backbone to run the company’s proprietary AI technology.
InterVenn Biosciences, a startup founded and headed by Filipino native Aldo Carrascoso, is pioneering a new AI-powered approach to predict, prevent and observe disease progression.
BoI said InterVenn is currently working on the development and commercialization of Dawn, assessing whether a patient is likely to benefit from immuno-oncology therapies.
The startup has also developed GLORI — a laboratory-developed test for ovarian cancer diagnosis.
This test recently complete clinical and analytical validation based on a multinational trial, VOCAL, carried out in South East Asia, including the Philippine General Hospital, National Kidney and Transplant Institute, and The Medical City in the Philippines, in the United States and Australia.
BOI added that InterVenn recently raised $278.1 million from over five seed rounds.
